Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Investment Manager

9 Dec 2015 07:00

RNS Number : 4348I
CATCo Reinsurance Opps Fund Ltd
08 December 2015
 

 

CATCo Reinsurance Opportunities Fund Ltd.

CATCo Investment Management Ltd. Completion of Acquisition and Restructuring

 

To: SFM, London Stock Exchange and Bermuda Stock Exchange

Date: 8 December 2015

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, OR INTO OR FROM CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN.

This announcement is an advertisement and not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in CATCo Reinsurance Opportunities Fund Ltd. (the "Company") or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.

Any investment decision must be made exclusively on the basis of the prospectus published by the Company on 29 September 2015 (the "Prospectus") and any supplementary prospectus or supplementary prospectuses thereto in connection with the admission of shares of the Company ("Shares") to trading on the London Stock Exchange's Specialist Fund Market.

Completion of Acquisition and Restructuring

On 8 December 2015, the Acquisition (that was announced on 10 September 2015) completed and substantially all of the assets of the Investment Manager were acquired by Markel. Substantially all of the business of the Investment Manager now operates as Markel CATCo Investment Management Ltd. ("Markel CATCo") and the Investment Manager's management team, led by Chief Executive Officer Anthony Belisle, has transitioned into commensurate roles at Markel CATCo and continues to operate the business from its Hamilton, Bermuda headquarters, now under Markel's ultimate ownership.

As a result of the completion of the Acquisition, the Company will conduct substantially all of its investment activities (other than in Run-Off Investments) through the Markel CATCo Diversified Fund (the "Markel CATCo Master Fund"), a segregated account of Markel CATCo Reinsurance Fund Ltd. (the "Markel CATCo SAC"), instead of the Master Fund, being CATCo Diversified Fund, a segregated account of CATCo Reinsurance Fund Ltd.

The Restructuring has been implemented as contemplated in the Prospectus and as further described below.

In accordance with the Prospectus Rules, the Company will in due course publish a supplementary prospectus in connection with the above.

Terms used and not defined in this announcement have the meanings given in the Prospectus.

 

Implementation of the Restructuring

To effect the Restructuring, the Company has agreed that its investment in the Master Fund will be redeemed as at 1 January 2016 and 100% of the cash or other assets that would otherwise have been distributed to the Company shall be reinvested into the Markel CATCo Master Fund. It is anticipated that, based on the most recent NAV and side pocket information, as at 31 October 2015, approximately 98% of the Company's NAV will be reinvested in this manner. The remainder of its investment in the Master Fund (comprising SP Shares in respect of Side Pocket Investments only) will be wound-down as and when the Run-Off Investments cease to be in run-off.

Following the completion of the Restructuring, the Company intends to conduct substantially all of its investment activities (other than: (a) in the period prior to the redemption of its Master Fund Shares as at 1 January 2016; and (b) in relation to Run-Off Investments) through the Markel CATCo Master Fund rather than the Master Fund, and all new reinsurance business will be conducted via Markel CATCo Re Ltd. (the "Markel CATCo Reinsurer"), rather than the Reinsurer. No further investments will be made by the Company in the Master Fund.

In addition, all of the net proceeds from the Initial Placing and Offer (net of any funds required for working capital purposes) are expected to be invested directly in the Markel CATCo Master Fund on or around 1 January 2016. The proceeds of any Subsequent Placing under the Placing Programme (net of the expenses of such issues and funds required for working capital purposes) will also be invested in the Markel CATCo Master Fund.

No further investments will be made by the Company in the Master Fund; however, the Company will retain a proportion of its holding in the Master Fund in respect of any Run-Off Investments, which will be wound-down as and when the Run-Off Investments cease to be in run-off. Cash received by the Master Fund when Run-Off Investments are wound-down will be distributed to Master Fund Shareholders (including the Company) on the redemption of their Master Fund Shares. The Company intends to use such amount for investment purposes.

Consequently, from early January 2016 onwards, the Company is expected to invest in both the Markel CATCo Master Fund and, until the Run-Off Investments have been wound-down, the Master Fund. In connection with this, the Company has revised its investment policy such that, with effect from 1 January 2016, substantially all of its assets will be invested in the Markel CATCo Master Fund. Neither: (a) the Company's continued investment in the Master Fund in connection with any Run-Off Investments; nor (b) the Company's entry into the Investor Transfer Direction and the Subscription Agreement (each as defined below), shall constitute a breach of the Company's investment policy. The Board does not consider that such changes amount to a material change to the Company's investment policy as it considers the Master Fund and the Markel CATCo Master Fund to represent materially the same investment proposition as they are materially the same in nature and have been established on materially the same terms.

New Material Contracts

In connection with the completion of the Restructuring, the Company has entered into each of the following material contracts, in each case on 8 December 2015:

The Investor Transfer Direction

Under the direction from the Company to the Master Fund SAC (the "Investor Transfer Direction"), the Company has agreed to: (a) redeem, as of 1 January 2016, all of its Master Fund Shares (save for any SP Shares); and (b) immediately upon such redemption, contribute the full amount of such proceeds to the Markel CATCo Master Fund in accordance with the Subscription Agreement, in lieu of any distribution being made to the Company.

The Investor Transfer Direction further provides that the following transactions are intended to occur on or around 1 January 2016 (in addition to the cash subscription into the Markel CATCo Master Fund): (a) the Reinsurance Agreements relating to certain risk exposures that are scheduled to terminate after 31 December 2015 will be transferred by novation from the related segregated accounts at the Reinsurer to the corresponding segregated accounts the Markel CATCo Reinsurer; (b) the assets of the Master Fund and the Reinsurer linked to the segregated accounts described in (a) will, at the direction of the relevant investors, be contributed to the corresponding segregated accounts at the Markel CATCo Master Fund and the Markel CATCo Reinsurer; and (c) other assets of or attributable to the Master Fund will, at the direction of the relevant investors, be contributed to the Markel CATCo Master Fund.

The Subscription Agreement

The subscription agreement entered into by the Company in connection with its investment in the Markel CATCo Master Fund under the Investor Transfer Direction (the "Subscription Agreement"), contains the terms and conditions on which the Company's subscription for Markel CATCo Master Fund Shares pursuant to the Investor Transfer Direction will be made. The Subscription Agreement is on materially the same terms as the Master Fund Subscription Agreement. Any further subscription by the Company for shares in the Markel CATCo Master Fund is expected to be made on the terms of the Subscription Agreement.

The New Investment Management Agreement

Under the investment management agreement between the Company and Markel CATCo (the "New Investment Management Agreement"), the Company has appointed Markel CATCo as its investment manager in place of the Investment Manager, except in relation to certain portfolio management services for the Run-Off Investments, which will continue to be provided by the Investment Manager. Save for the foregoing, the New Investment Management Agreement is on materially the same terms as the Investment Management Agreement, other than the monthly fee payable to Markel CATCo for secretarial, accounting and administrative services will be 1/12 of US$275,000 (rather than of US$200,000) and the indemnity given to Markel CATCo by the Company is also in favour of Markel CATCo's subsidiaries and other affiliates, and their respective officers, directors, employees and agents.

The New Control Agreement

The control agreement between the Company, Markel CATCo, the Markel CATCo SAC (in respect of the Markel CATCo Master Fund) and the Markel CATCo Reinsurer (the "New Control Agreement") provides the Company with control of its investment in the Markel CATCO Master Fund on materially the same terms as the Control Agreement and, inter alia, prohibits the Markel CATCo SAC from changing the investment objectives, policies and restrictions of the Markel CATCo Master Fund, without the prior consent of the Company.

The Revised Investment Management Agreement

The Investment Management Agreement has been amended and restated (the "Revised Investment Management Agreement") such that the Investment Manager's appointment is limited to providing certain portfolio management services in respect of the Run-Off Investments for such time as the Company retains an investment in the Master Fund. In addition, the Investment Manager is no longer appointed to provide any secretarial, accounting or administrative services all of which will henceforth be provided by Markel CATCo. Save for the foregoing reduction in the scope of services, the Revised Investment Management Agreement is on materially the same terms as the Investment Management Agreement.

The Revised Control Agreement

The Control Agreement has been amended and restated (the "Revised Control Agreement") (on materially the same terms as the Control Agreement) pursuant to which, inter alia, the Master Fund SAC shall not, in respect of the Master Fund, without the prior consent of the Company, change its investment objectives, policies and restrictions.

The New Placing Agreement

The Company has entered into a placing agreement with Markel CATCo and Numis (the "New Placing Agreement"), under which Numis has been appointed as the Company's placing agent in relation to the Placing Programme and any Subsequent Placings. The New Placing Agreement supersedes the Placing Agreement, other than in relation to the publication of the Prospectus, the Initial Placing and Offer and the Initial Admission and as provided under the Supplemental Agreement to the Placing Agreement.

The New Placing Agreement is on materially the same terms as the Placing Agreement, other than as follows: (a) Markel CATCo does not accept any liability, make any representation or warranty, or undertake to indemnify Numis or any other indemnified party in respect of the Investment Manager, the Master Fund SAC, the Master Fund, the Reinsurer, any Side Pocket Investments referable to the Master Fund, any Reinsurance Agreements with the Reinsurer, the Initial Placing and Offer or, in relation to any period prior to the date of the New Placing Agreement, any accounting or financial matters (instead giving comfort on the terms of the New Placing Agreement in respect of itself, the Markel CATCo SAC, the Markel CATCo Master Fund and the Markel CATCo Reinsurer and, on and from the date of the New Placing Agreement, accounting and financial information); and (b) Numis (acting in good faith) shall be entitled to terminate the New Placing Agreement if any representations or warranties given by the Company and/or the Investment Manager under the Placing Agreement (as supplemented by the Supplemental Agreement to the Placing Agreement (as defined below)) are not true and accurate or have become misleading or would be if repeated by reference to the facts subsisting at the time.

Supplemental Agreement to the Placing Agreement

The Company has entered into a supplemental agreement to the Placing Agreement with the Investment Manager and Numis (the "Supplemental Agreement to the Placing Agreement") which provides that, save as set out below, the Placing Agreement will cease to have any further force and effect in relation to the Placing Programme and any Subsequent Placings and that the Investment Manager shall have no liability to Numis or the Company in relation thereto. Notwithstanding this, the Placing Agreement will remain in full form and effect in relation to the publication of the Prospectus, the Initial Placing and Offer and the Initial Admission.

Under the Supplemental Agreement to the Placing Agreement, the Investment Manager will continue to represent and warrant that certain of the warranties set out in the Placing Agreement as well as certain information relating to its track record are true, accurate and not misleading as at the date of the Supplemental Agreement to the Placing Agreement and (subject to any contrary notices) in each period commencing five Business Days before a subsequent Admission and terminating on such subsequent Admission, as if repeated by reference to the facts and circumstances at all such times. The Investment Manager shall have no liability for any breach of any of these representations and warranties and neither Numis nor any other indemnified party will be entitled to make an indemnity claim in relation to such breach. Rather, any such breach will permit Numis to terminate the New Placing Agreement in accordance with its terms.

Contacts

For investor enquiries please contact:

 

Judith Wynne,Company Secretary and General CounselMarkel CATCo Investment Management Ltd.

Telephone: +1 441 493 9000

Email: judith.wynne@markelcatco.com

 

Mark WayFund Operations & Investor Relations DirectorMarkel CATCo Investment Management Ltd.

Telephone: +1 441 493 9000

Email: mark.way@markelcatco.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0) 20 7260 1000

 

IMPORTANT NOTICE

 

This announcement is not for release, publication or distribution (directly or indirectly) in or into the United States, Australia, Canada, The Republic of South Africa or Japan or to any "US Person" as defined in Regulation S under the United States Securities Act of 1933, as amended, (the "Securities Act") or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. This announcement does not constitute an offer of or a solicitation of any offer to buy the securities referred to herein in the United States, Australia, Canada, The Republic of South Africa or Japan or in any other jurisdiction where such offer or sale would be unlawful. No recipient may distribute, or make available, this announcement (directly or indirectly) to any other person. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of this announcement may in certain jurisdictions be restricted by law. Accordingly, recipients of this announcement represent that they are able to receive this announcement without contravention of any applicable legal or regulatory restrictions in the jurisdiction in which they reside or conduct business.

 

This announcement has been prepared by the Company and is the sole responsibility of the Company. No liability whatsoever (whether in negligence or otherwise) arising directly or indirectly from the use of this announcement is accepted and no representation, warranty or undertaking, express or implied, is or will be made by the Company, Numis Securities Limited ("Numis"), Markel CATCo (and its affiliates) or any of their respective directors, officers, employees, advisers, representatives or other agents ("Agents") for any information or any of the opinions contained herein or for any errors, omissions or misstatements. None of the Company, Numis, Markel CATCo (and its affiliates) nor any of their Agents makes or has been authorised to make any representations or warranties (express or implied) in relation to Company or as to the truth, accuracy or completeness of this announcement, or any other written or oral statement provided.

This announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis of any decision in respect of the Company or other evaluation of securities of the Company or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities. Neither the issue of this announcement nor any part of its contents constitutes an offer to sell or invitation to purchase any securities of the Company and no information set out in this announcement or referred to in other written or oral information is intended to form the basis of any contract of sale, investment decision or any decision to purchase any securities in the Company or any other entity. Any investment decision must be made solely on the basis of the Prospectus and any supplementary prospectus or supplementary prospectuses thereto.

Numis, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for the Company and no-one else in connection with the Placing Programme and any Subsequent Placings thereunder and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Numis or for providing advice in relation to the Placing Programme and any Subsequent Placings thereunder.

 

Apart from the responsibilities and liabilities, if any, which may be imposed by the Financial Services and Markets Act 2000 or the regulatory regime established thereunder, neither Numis nor any of its affiliates or any of its or their Agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from this announcement) or any other information relating to the Company, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUWSARVSAURUA
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.